3M's new immunomodulators induce TNF-alpha, IFN-alpha biosynthesis, inhibit Th2 immune response March 15, 2000
Dynavax's ragweed immunotherapy has improved safety according to preclinical and clinical data March 9, 2000
Prostanoid receptor ligands with selectivity for EP4 receptors designed by Ono researchers March 9, 2000
Celgene accelerates development of second-generation compounds from the thalidomide class March 1, 2000
RSS